CA2244679A1 - Preparation contenant du tranilast pour application externe et methode de production de cette preparation - Google Patents

Preparation contenant du tranilast pour application externe et methode de production de cette preparation

Info

Publication number
CA2244679A1
CA2244679A1 CA 2244679 CA2244679A CA2244679A1 CA 2244679 A1 CA2244679 A1 CA 2244679A1 CA 2244679 CA2244679 CA 2244679 CA 2244679 A CA2244679 A CA 2244679A CA 2244679 A1 CA2244679 A1 CA 2244679A1
Authority
CA
Canada
Prior art keywords
tranilast
active ingredient
aqueous base
producing
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2244679
Other languages
English (en)
Other versions
CA2244679C (fr
Inventor
Masao Mori
Noriyasu Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lead Chemical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/JP1997/000283 external-priority patent/WO1997028793A1/fr
Publication of CA2244679A1 publication Critical patent/CA2244679A1/fr
Application granted granted Critical
Publication of CA2244679C publication Critical patent/CA2244679C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA 2244679 1996-02-07 1997-02-06 Preparation contenant du tranilast pour application externe et methode de production de cette preparation Expired - Fee Related CA2244679C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4549396 1996-02-07
JPHEI8-45493 1996-02-07
PCT/JP1997/000283 WO1997028793A1 (fr) 1996-02-07 1997-02-06 Preparation a usage externe comprenant du tranilast et processus de production de cette preparation

Publications (2)

Publication Number Publication Date
CA2244679A1 true CA2244679A1 (fr) 1997-08-14
CA2244679C CA2244679C (fr) 2007-08-07

Family

ID=29422271

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2244679 Expired - Fee Related CA2244679C (fr) 1996-02-07 1997-02-06 Preparation contenant du tranilast pour application externe et methode de production de cette preparation

Country Status (1)

Country Link
CA (1) CA2244679C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3135280A4 (fr) * 2014-04-24 2017-10-04 Omoidesouzou Co. Ltd. Agent limitant ou inhibiteur de la formation de fibres amiloïdes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3135280A4 (fr) * 2014-04-24 2017-10-04 Omoidesouzou Co. Ltd. Agent limitant ou inhibiteur de la formation de fibres amiloïdes
US11723889B2 (en) 2014-04-24 2023-08-15 Hideyasu Takata Amyloid fiber formation limiter or inhibitor

Also Published As

Publication number Publication date
CA2244679C (fr) 2007-08-07

Similar Documents

Publication Publication Date Title
HK1018218A1 (en) Tranilast-containing preparation for external application and method of producing the same
CA2007181A1 (fr) Compose pharmaceutique a liberation continue
AU6020494A (en) Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
EP2977043A3 (fr) Mousse pharmaceutique pénétrante
CA2158638A1 (fr) Composition et methode d'augmentation tissulaire
CA2416383A1 (fr) Feuille contenant des produits dermatologiques
EP1452172A3 (fr) Préparation pharmaceutique composite.
CA2282345A1 (fr) Composition pharmaceutique
CA2356310A1 (fr) Preparations externes contenant un medicament de base
CA2251982A1 (fr) Composition ophtalmique a temps de sejour prolonge au niveau de l'oeil
BG103325A (en) Analgetic preparation for external application
CA2161703A1 (fr) Formulations pour applications topiques, renfermant des substances polymeriques, des glycols et des glycerides
EP0682942A4 (fr) Nouvelle preparation absorbable par voie percutanee.
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
ATE227973T1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
EP0974349A4 (fr) Agent augmentant l'endurance athletique
CA2285985A1 (fr) Methode pour preparer des compositons liposomales aqueuses comprenant un principe actif essentiellement insoluble dans l'eau
BG103262A (en) Antimycotic gel with high degree of active substance release
AU2823997A (en) Pesticides comprising benzophenanthridine alkaloids
CA2244679A1 (fr) Preparation contenant du tranilast pour application externe et methode de production de cette preparation
CA2132528A1 (fr) Agent utilise comme anti-irritant
CA2224565A1 (fr) Agent pour combattre les parasites en pisciculture
WO2001028578A3 (fr) Composition pharmaceutique a base de pglu-glu-pro-nh2 et procede de traitement de maladies et de lesions cerebrales
KR927002996A (ko) 발모촉진용 조성물
KR927003530A (ko) 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed